|
FAM178A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.83399994980027E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.40879999677557E-08 |
| Normal-vs-Stage2 |
9.376600E-04 |
| Normal-vs-Stage3 |
4.359000E-03 |
| Normal-vs-Stage4 |
5.524400E-02 |
| Stage1-vs-Stage2 |
3.054400E-01 |
| Stage1-vs-Stage3 |
7.069800E-01 |
| Stage1-vs-Stage4 |
9.290000E-01 |
| Stage2-vs-Stage3 |
2.776400E-01 |
| Stage2-vs-Stage4 |
4.874400E-01 |
| Stage3-vs-Stage4 |
8.889200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.9207000151743E-09 |
| Normal-vs-AfricanAmerican |
3.48859999999007E-06 |
| Normal-vs-Asian |
2.520000E-01 |
| Caucasian-vs-AfricanAmerican |
7.417800E-01 |
| Caucasian-vs-Asian |
7.401800E-01 |
| AfricanAmerican-vs-Asian |
6.762800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.78800000255808E-08 |
| Normal-vs-Female |
1.48809997657651E-09 |
| Male-vs-Female |
1.060290E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.158070E-03 |
| Normal-vs-Extreme_Weight |
3.66940000000593E-05 |
| Normal-vs-Obese |
7.79059999844733E-08 |
| Normal-vs-Extreme_Obese |
3.814400E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.646400E-01 |
| Normal_Weight-vs-Obese |
7.528300E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.267000E-01 |
| Extreme_Weight-vs-Obese |
8.353500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.659800E-01 |
| Obese-vs-Extreme_Obese |
6.336200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.61149999999522E-05 |
| Normal-vs-Age(41-60Yrs) |
1.61070046189593E-11 |
| Normal-vs-Age(61-80Yrs) |
1.6119699999928E-05 |
| Normal-vs-Age(81-100Yrs) |
6.595800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.422200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.725000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.401200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.221400E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.901100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.336040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.26739746370208E-11 |
| Normal-VS-Type2 PRCC |
3.240100E-02 |
| Normal-VS-KIRP CIMP |
1.172190E-02 |
| Normal-VS-Unclassified PRCC |
2.1704999999983E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.13450000000159E-06 |
| Type1 PRCC-VS-KIRP CIMP |
7.999000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.120600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.390200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.418630E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.299200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.246100E-04 |
| Normal-vs-N1 |
8.766000E-04 |
| Normal-vs-N2 |
3.944600E-01 |
| N0-vs-N1 |
1.210430E-01 |
| N0-vs-N2 |
5.103000E-01 |
| N1-vs-N2 |
2.631000E-01 |
|
|
